Task: Answer the multiple choice question.
Query: Which compound exhibits a -3.247% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCC(=O)Nc1sc2c(c1C#N)CC(C)(C)NC2(C)C
b.) Cc1cccc(N2CCN(C(c3ccc(N(C)C)cc3)c3nnnn3C(C)(C)C)CC2)c1C
c.) CCN(CC(=O)NCc1ccc(F)cc1)C(=O)/C=C/c1ccc(OC)cc1
Answer: a. CCC(=O)Nc1sc2c(c1C#N)CC(C)(C)NC2(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1sc2c(c1C#N)CC(C)(C)NC2(C)C
CCC(=O)Nc1sc2c(c1C#N)CC(C)(C)NC2(C)C
N-(3-cyano-5,5,7,7-tetramethyl-4,6-dihydrothieno[2,3-c]pyridin-2-yl)propanamide